"10.1371_journal.pone.0068876","plos one","2013-07-23T00:00:00Z","Christine Breynaert; Tom Dresselaers; Clémentine Perrier; Ingrid Arijs; Jonathan Cremer; Leentje Van Lommel; Kristel Van Steen; Marc Ferrante; Frans Schuit; Séverine Vermeire; Paul Rutgeerts; Uwe Himmelreich; Jan L Ceuppens; Karel Geboes; Gert Van Assche","Translational Research Center for Gastrointestinal Disorders (TARGID), Department of Clinical and Experimental Medicine, KU Leuven, Leuven, Belgium; Laboratory of Clinical immunology, Department of Microbiology and Immunology, KU Leuven, Leuven, Belgium; Biomedical MRI/MoSAIC, Department of Imaging and Pathology, KU Leuven, Leuven, Belgium; Gene Expression Unit, Department of Cellular and Molecular Medicine, KU Leuven, Leuven, Belgium; Montefiore Institute, System and Modeling Unit, University of Liège, Liège, Belgium; Translational Cell and Tissue Research, Department of Imaging and Pathology, KU Leuven, Leuven, Belgium","Conceived and designed the experiments: CB TD CP J. Ceuppens KG GVA. Performed the experiments: CB TD J. Cremer LVL. Analyzed the data: CB TD IA KVS J. Ceuppens UH KG GVA. Contributed reagents/materials/analysis tools: LVL KV FS MF SV PR J. Ceuppens UH GVA. Wrote the paper: CB TD J. Ceuppens KG GVA. Critical revision of the manuscript for intellectual content: MF FS SV PR UH J. Ceuppens.","MF: Financial support for research from: Janssen Biologics. Lecture fee(s) from: Merck, Tillotts, Ferring, Abbott. Consultancy for: Abbott, Merck, Janssen Biologics. SV: Financial support for research from: UCB Pharma, MSD, Abbvie, Foundation for Scientific Research Flanders, FWO Vlaanderen. Lecture fee(s) from: Abbvie, Merck, Ferring, UCB Pharma, Centocor. Consultancy for: UCB Pharma, AstraZeneca, Ferring, Abbvie, Merck, Ferring, Shire, Pfizer. PR: Financial support for research from: UCB Pharma, Abbvie, Janssen Biologics, Merck, Prometheus. Lecture fee(s) from: Abbvie, Merck. Consultancy for: Amgen, Merck, UCB Pharma, Genentech, BMS, Abbvie, Janssen Biologics, Millenium, Neovacs, Actogenics, Prometheus. GVA: Financial support for research from: Abbvie, Ferring, Foundation for Scientific Research Flanders, FWO Vlaanderen, Broad Medical Research Program of the Broad Foundation (IBD-0319R). Lecture fee(s) from: Janssen-Cilag, Merck, Abbvie. Consultancy for: PDL BioPharma, UCB Pharma, Sanofi-Aventis, Abbvie, Ferring; Novartis, Biogen Idec, Janssen Biologics, NovoNordisk, Zealand Pharma A/S, Millenium/Takeda, Shire, Novartis, BMS. None of the above was for this specific study. This does not alter the authors adherence to all the PLOS ONE policies on sharing data and materials.","2013","07","Christine Breynaert","CB",15,TRUE,4,3,5,3,TRUE,TRUE,TRUE,2,"14;15",TRUE
